drugset / Trial / NCT07160127

A Clinical Study of Chinese Herbal Formula TJAOA103 in Treating Genitourinary Syndrome of Menopause

NCT07160127 ↗

Phase 0 Not yet recruiting 113 enrolled Tongji Hospital
NaSingle-groupOpen-labelTreatment

Summary

The goal of this clinical trial is to learn if Chinese herbal formula TJAOA103 works to treat genitourinary syndrome of menopause (GSM). It will also learn about the safety of TJAOA103. The main questions it aims to answer are: 1. Does TJAOA103 alleviate the symptoms of GSM in participants or have any other benefits? 2. What medical problems do participants have when taking TJAOA103? Researchers will conduct a pre-post comparison to see if TJAOA103 works to treat GSM. Participants will: 1. Take TJAOA103 twice daily for 4 to 12 weeks. 2. Complete the tests and/or questionnaires on schedule through online follow-up or outpatient visits. 3. Record their use of TJAOA103 and any adverse events.

Timeline

Start
2025-09-15
Primary completion
2027-06-15
Completion
2027-09-15

Drugs

EvaluationDrugModalityDoseRoute
Subject TJAOA103 Traditional medicine (herbal / TCM) — Oral

Indications